Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Livzon Pharmaceutical Group Inc Class H (HK:1513)
HKEX:1513
Holding HK:1513?
Track your performance easily
1513 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$22.35 - HK$34.00
Previous CloseHK$26.2
Volume864.45K
Average Volume (3M)691.56K
Market Cap
HK$32.59B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)11.0
Beta0.63
Next Earnings
Mar 26, 2025EPS Estimate
HK$0.43Last Dividend Ex-Date
Jul 08, 2024Dividend Yield5.56%
Share Statistics
EPS (TTM)2.38
Shares OutstandingN/A
10 Day Avg. Volume574,062
30 Day Avg. Volume691,563
Standard Deviation0.10
R-Squared0.27
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1.76
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$22.96Price Target Upside-12.38% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering1
Livzon Pharmaceutical Group News
PremiumCompany Announcements
Livzon Pharmaceutical Reports Mixed Q3 2024 Financial Results
PremiumCompany Announcements
Livzon Pharmaceutical Proposes New Non-Executive Director
PremiumCompany Announcements
Livzon Pharmaceutical Group Plans Key Meeting for 2024PremiumCompany Announcements
Livzon Pharmaceutical Delays Circular Dispatch to 2024
PremiumCompany Announcements
Livzon Pharma’s Generic Drug Receives Regulatory Green LightPremiumCompany Announcements
Livzon Pharma Announces Board and Committee Structure
PremiumCompany Announcements
Livzon Pharmaceutical Announces Director ResignationOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.76% Mutual Funds
― Other Institutional Investors
95.85% Public Companies and
Individual Investors
1513 FAQ
What was Livzon Pharmaceutical Group Inc Class H’s price range in the past 12 months?
Livzon Pharmaceutical Group Inc Class H lowest stock price was HK$22.35 and its highest was HK$34.00 in the past 12 months.
What is Livzon Pharmaceutical Group Inc Class H’s market cap?
Currently, no data Available
When is Livzon Pharmaceutical Group Inc Class H’s upcoming earnings report date?
Livzon Pharmaceutical Group Inc Class H’s upcoming earnings report date is Mar 26, 2025 which is in 123 days.
How were Livzon Pharmaceutical Group Inc Class H’s earnings last quarter?
Livzon Pharmaceutical Group Inc Class H released its earnings results on Oct 23, 2024. The company reported HK$0.58 earnings per share for the quarter, missing the consensus estimate of HK$0.613 by -HK$0.032.
Is Livzon Pharmaceutical Group Inc Class H overvalued?
According to Wall Street analysts Livzon Pharmaceutical Group Inc Class H’s price is currently Overvalued.
Does Livzon Pharmaceutical Group Inc Class H pay dividends?
Livzon Pharmaceutical Group Inc Class H pays a Annually dividend of HK$1.46 which represents an annual dividend yield of 5.56%. See more information on Livzon Pharmaceutical Group Inc Class H dividends here
What is Livzon Pharmaceutical Group Inc Class H’s EPS estimate?
Livzon Pharmaceutical Group Inc Class H’s EPS estimate is HK$0.43.
How many shares outstanding does Livzon Pharmaceutical Group Inc Class H have?
Livzon Pharmaceutical Group Inc Class H has 307,052,430 shares outstanding.
What happened to Livzon Pharmaceutical Group Inc Class H’s price movement after its last earnings report?
Livzon Pharmaceutical Group Inc Class H reported an EPS of HK$0.58 in its last earnings report, missing expectations of HK$0.613. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Livzon Pharmaceutical Group Inc Class H?
Currently, no hedge funds are holding shares in HK:1513
---
Livzon Pharmaceutical Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.92%
12-Months-Change
Fundamentals
Return on Equity
14.46%
Trailing 12-Months
Asset Growth
4.56%
Trailing 12-Months
Company Description
Livzon Pharmaceutical Group Inc Class H
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio primarily comprises of western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drugs address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, as well as blood and hemopoietic system. The Company distributes its products within domestic market and to overseas markets.
---
1513 Stock 12 Month Forecast
Average Price Target
HK$22.96
▼(-12.38% Downside)
Technical Analysis
Livzon Pharmaceutical Group
―
Sinopharm Group Co
―
Takeda Pharmaceutical Company
―
Zoetis
―
Novartis
―
Best Analysts Covering 1513
1 Year
1 Year Success Rate
3/4 ratings generated profit
1 Year Average Return
+5.10%
reiterated a sell rating 30 days ago
Copying Sean Wu CFA's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +5.10% per trade.
---